LB322 (Bcl-2 from ATG to -3934) Citations (12)

Originally described in: A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells.
Heckman CA, Mehew JW, Ying GG, Introna M, Golay J, Boxer LM J Biol Chem. 2000 Mar 3. 275(9):6499-508. PubMed Journal

---

Articles Citing LB322 (Bcl-2 from ATG to -3934)

Articles
TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. Dittmer S, Kovacs Z, Yuan SH, Siszler G, Kogl M, Summer H, Geerts A, Golz S, Shioda T, Methner A. J Cell Sci. 2011 Jan 15;124(Pt 2):252-60. doi: 10.1242/jcs.068759. Epub 2010 Dec 15. PubMed
DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells. Zhao R, Han C, Eisenhauer E, Kroger J, Zhao W, Yu J, Selvendiran K, Liu X, Wani AA, Wang QE. Mol Cancer Res. 2014 Mar;12(3):370-80. doi: 10.1158/1541-7786.MCR-13-0281. Epub 2013 Nov 18. PubMed
RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2. Wang X, Zhou M, Fu Y, Sun T, Chen J, Qin X, Yu Y, Jia J, Chen C. PLoS One. 2016 Mar 23;11(3):e0152142. doi: 10.1371/journal.pone.0152142. eCollection 2016. PubMed
MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1. Sun YP, Lu F, Han XY, Ji M, Zhou Y, Zhang AM, Wang HC, Ma DX, Ji CY. Oncotarget. 2016 Mar 22. doi: 10.18632/oncotarget.8252. PubMed
Human Telomeric G-Quadruplex Selective Fluoro-Isoquinolines Induce Apoptosis in Cancer Cells. Maiti S, Saha P, Das T, Bessi I, Schwalbe H, Dash J. Bioconjug Chem. 2018 Apr 18;29(4):1141-1154. doi: 10.1021/acs.bioconjchem.7b00781. Epub 2018 Feb 23. PubMed
Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex. Dutta D, Debnath M, Muller D, Paul R, Das T, Bessi I, Schwalbe H, Dash J. Nucleic Acids Res. 2018 Jun 20;46(11):5355-5365. doi: 10.1093/nar/gky385. PubMed
Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4. Kim S, Ko D, Lee Y, Jang S, Lee Y, Lee IY, Kim S. Sci Rep. 2019 Jul 10;9(1):10003. doi: 10.1038/s41598-019-46447-7. PubMed
Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity. Kavazovic I, Han H, Balzaretti G, Slinger E, Lemmermann NAW, Ten Brinke A, Merkler D, Koster J, Bryceson YT, de Vries N, Jonjic S, Klarenbeek PL, Polic B, Eldering E, Wensveen FM. PLoS Biol. 2020 Mar 17;18(3):e3000648. doi: 10.1371/journal.pbio.3000648. eCollection 2020 Mar. PubMed
TGF-beta causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization. Li Y, Zhang B, Xiang L, Xia S, Kucuk O, Deng X, Boise LH, Dong JT. Theranostics. 2020 Jun 18;10(17):7656-7670. doi: 10.7150/thno.44567. eCollection 2020. PubMed
TFEB promotes BCL-2 expression by upregulating its promoter activity in the t(6;11) translocation renal cell carcinomas. Zhan HQ, Qin R, Li YL, Liu MM, Gan L. Am J Transl Res. 2021 Aug 15;13(8):8804-8818. eCollection 2021. PubMed
Contrasting roles for G-quadruplexes in regulating human Bcl-2 and virus homologues KSHV KS-Bcl-2 and EBV BHRF1. Kumar S, Ramamurthy C, Choudhary D, Sekar A, Patra A, Bhavesh NS, Vivekanandan P. Sci Rep. 2022 Mar 23;12(1):5019. doi: 10.1038/s41598-022-08161-9. PubMed
SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagy. Yu J, Han L, Yang F, Zhao M, Zhou H, Hu L. Bioengineered. 2022 Jun;13(6):14125-14137. doi: 10.1080/21655979.2022.2081463. PubMed

If you have published an article using this material, please email us at to have your article added to this page.